Global Wilson’s Disease (WD) Epidemiology Forecast Report 2021-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Wilson’s Disease (WD) – Epidemiology Forecast – 2030” report has been added to ResearchAndMarkets.com’s offering.

This ‘Wilson’s Disease (WD) – Epidemiology Forecast – 2030’ report delivers an in-depth understanding of and historical and forecasted epidemiology of Wilson’s disease (WD) in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Wilson’s disease (WD) Epidemiology

The Wilson’s disease (WD) epidemiology division provides insights about the historical and current patient pool along with the forecasted trend for every seven major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.

Key Findings

The disease epidemiology covered in the report provides historical as well as forecasted WD epidemiology segmented as the total prevalent cases of Wilson’s disease (WD), diagnosed prevalent cases of Wilson’s disease (WD), prevalent cases of Wilson’s disease (WD) by clinical manifestation. The report includes the prevalence scenario of Wilson’s disease (WD) symptoms in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.

Country-wise, Wilson’s disease (WD) Epidemiology

The epidemiology segment also provides Wilson’s disease (WD) epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

The total prevalent population of Wilson’s disease (WD) in the 7MM countries was estimated to be 35,509 in 2020, and it is expected to increase at a CAGR of 0.07% during the study period, i.e., 2018-2030.

• As per the estimates, Japan has the highest prevalent population of Wilson’s disease (WD) in the 7MM.
• Among the EU5 countries, Germany had the highest prevalent population of Wilson’s disease (WD). On the other hand, Spain had the lowest number, 797 cases in 2020.

Scope of the Report

• Wilson’s disease (WD) report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
• Wilson’s disease (WD) Epidemiology Report and Model provide an overview of the risk factors and global trends of Wilson’s disease (WD) in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
• The report provides insight into the historical and forecasted patient pool of Wilson’s disease (WD) in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
• The report helps recognize the growth opportunities in the 7MM concerning the patient population
• The report assesses the disease risk and burden and highlights the unmet needs of Wilson’s disease (WD).
• The report provides the segmentation of Wilson’s disease (WD) epidemiology by prevalent Cases of Wilson’s disease (WD) in the 7MM
• The report provides the segmentation of Wilson’s disease (WD) epidemiology by diagnosed prevalent cases of Wilson’s disease (WD) in 7MM
• The report provides the segmentation of Wilson’s disease (WD) epidemiology by prevalent cases of Wilson’s disease (WD) by clinical manifestation in 7MM

Report Highlights

• 10-year Forecast of Wilson’s disease (WD) epidemiology
• 7MM Coverage
• Total Prevalent Cases of Wilson’s disease (WD)
• Diagnosed prevalent cases of Wilson’s disease (WD)
• Prevalent cases of Wilson’s disease (WD) by clinical manifestation

KOL Views

The publisher interviews KOLs, and SME’s Opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

• What will be the growth opportunities in the 7MM concerning the patient population about Wilson’s disease (WD)?
• What are the key findings of Wilson’s disease (WD) epidemiology across 7MM, and which country will have the highest number of patients during the forecast period (2021-2030)?
• What would be the total number of patients with Wilson’s disease (WD) across the 7MM during the forecast period (2021-2030)?
• Among the EU5 countries, which country will have the highest number of patients during the forecast period (2021-2030)?
• At what CAGR the patient population is expected to grow by 7MM during the forecast period (2021-2030)?
• What are the currently available treatments for Wilson’s disease (WD)?

Key Topics Covered:

1 Key Insights

2 Report Introduction

3 Wilson’s disease Epidemiology Overview at a Glance

3.1 Patient Share (%) Distribution of Wilson’s disease in 2018

3.2 Patient Share (%) Distribution of Wilson’s disease in 2030

4 Executive Summary of Wilson’s disease

5 Disease Background and Overview

5.1 Introduction

5.2 Symptoms

5.3 Etiology

5.4 Clinical Manifestation

5.5 Copper Metabolism

5.6 Pathogenesis

5.7 Diagnosis

6 Epidemiology and Patient Population

6.1 Key Findings

6.2 7MM Total Prevalent Patient Population of Wilson’s disease

6.3 Epidemiology of Wilson’s disease

6.4 The United States

6.4.1 Prevalent Cases of Wilson’s disease in the United States

6.4.2 Diagnosed Prevalent Cases of Wilson’s disease in the United States

6.4.3 Prevalent cases of Wilson’s disease based on Clinical Manifestation in the US

6.5 EU5

6.5.1 Germany

6.5.2 France

6.5.3 Italy

6.5.4 Spain

6.5.5 United Kingdom

6.6 Japan

6.6.1 Prevalent Cases of Wilson’s disease in Japan

6.6.2 Diagnosed Prevalent Cases of Wilson’s disease in Japan

6.6.3 Prevalent cases of Wilson’s disease based on Clinical Manifestation in Japan

7 Treatment of Wilson’s disease

8 Organizations contributing towards Wilson’s disease

9 Patient Journey

10 Case Reports

11 KOL Views

12 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/ncgmx9

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900